Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
mankind pharma bsv deal
November 2024
October 2024
Mankind Pharma shares end 8-session losing streak on acquisition of BSV
The pharma company has acquired 100% stake in Bharat Serums and Vaccines Ltd (BSV), which will be funded through a combination of internal accruals and external debt.
